Mitochondrial dynamics machinery

The mitochondrial dynamics machinery is a coordinated system of proteins, primarily large GTPases of the dynamin family, that regulate the continuous fusion and fission of mitochondria to maintain organelle health and cellular homeostasis [NIH, 2021]. Key components include Dynamin-related protein 1 (DRP1), which mediates fission, and Mitofusins (MFN1/2) and Optic atrophy 1 (OPA1), which facilitate outer and inner membrane fusion, respectively [Frontiers, 2021]. This machinery is essential for mitochondrial quality control, metabolic adaptation, and the regulation of apoptosis [NIH, 2019]. Dysregulation of these processes, often characterized by excessive mitochondrial fragmentation, is implicated in the pathogenesis of neurodegenerative diseases like Parkinson's and Alzheimer's, as well as in cancer progression and cardiovascular dysfunction [PLOS, 2025; ACNR, 2014]. Therapeutic targeting of the machinery involves small molecules like Mdivi-1 that inhibit DRP1-mediated fission or activators like leflunomide that promote fusion [NIH, 2019; NIH, 2021]. However, because mitochondria are vital for almost all eukaryotic cells, pharmacological intervention faces significant challenges regarding tissue selectivity and the potential for systemic toxicity [NIH, 2009].

Other names

Mitochondrial fusion and fission machineryMitochondrial remodeling machineryMitochondrial division and fusion machineryMitochondrial quality control system

Modulation of mitochondrial morphology through the inhibition of fission-mediating GTPases (e.g., DRP1) or the activation of fusion-mediating proteins (e.g., MFN2, OPA1) to restore mitochondrial network homeostasis [NIH, 2019; NIH, 2021].